[Congressional Record Volume 172, Number 49 (Wednesday, March 18, 2026)]
[Senate]
[Page S1237]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 4519. Mr. LUJAN submitted an amendment intended to be proposed by 
him to the bill S. 1383, to establish the Veterans Advisory Committee 
on Equal Access, and for other purposes; which was ordered to lie on 
the table; as follows:

        At the appropriate place, insert the following:

     SEC. __. GAO STUDY ON DOGE MEDICAL RESEARCH FUNDING 
                   REDUCTIONS.

       (a) In General.--The Comptroller General of the United 
     States (referred to in this section as the ``Comptroller 
     General'') shall conduct a study on the impact of reductions 
     in Federal funding recommended by the Department of 
     Government Efficiency on the following types of medical 
     research:
       (1) Neurological research, including relating to stroke, 
     Alzheimer's disease and related dementia, and other 
     neurological conditions.
       (2) Cancer research, including basic, translational, and 
     clinical cancer research.
       (3) Pandemic preparedness, including research and 
     development related to emerging infectious diseases, vaccine 
     development, surveillance, and public health preparedness.
       (4) HIV/AIDS research, including relating to prevention, 
     treatment, and cure of HIV/AIDS.
       (5) Women's health research, including relating to 
     addressing conditions and health outcomes affecting women 
     across the lifespan, including maternal health.
       (b) Requirements.--The study under subsection (a) shall 
     include--
       (1) an analysis of changes in funding levels over the 4-
     year period immediately preceding the date of enactment of 
     this Act for each type of research described in paragraphs 
     (1) through (5) of subsection (a);
       (2) an assessment of the impact of such funding changes 
     on--
       (A) the number and scope of active research projects;
       (B) clinical trials and translational research;
       (C) workforce capacity, including researchers, clinicians, 
     and trainees;
       (D) the pace of scientific discovery and innovation;
       (E) research institutions in each State;
       (F) neurological and cancer research relevant to veterans 
     and service members; and
       (G) the global leadership of the United States in 
     biomedical research;
       (3) an evaluation of any impacts on patient outcomes, where 
     data is available;
       (4) an analysis of geographic disparities, including 
     impacts on rural and underserved communities;
       (5) any delays in life-saving treatments attributable to 
     such changes in funding levels; and
       (6) such recommendations as the Comptroller General 
     determines appropriate.
       (c) Report.--Not later than 18 months after the date of 
     enactment of this Act, the Comptroller General shall submit 
     to Congress a report on the study conducted under subsection 
     (a).
                                 ______